There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
The drug industry usually defends the high price on drugs – the latest cancer therapies are tipping the scales at $100,000 a year – by pointing to the large sums it spends on research and development. It is true that drug firms spend a larger share of th
MACCLESFIELD, ENGLAND - FEBRUARY 02: A general view of buildings and signage at the Macclesfield site of pharmaceutical company AstraZenica on February 2, 2012 in Macclesfield, England. The global pharmaceutical company has today announced that it is... View Photo »
Matt's experience at AstraZeneca UK and his insights about the EU market will help Myoderm to do an even better job of providing the optimal sourcing solution for each of our clients. I know he'll be a great addition to our team.
The U.K.'s cost-effectiveness watchdog has asked Roche ($RHHBY) for more information on Tarceva as a first-line treatment for non-small cell lung cancer. The National Institute for Health and Clinical Excellence noted that a rival drug from AstraZeneca (
Drugmakers are getting creative about capturing sales even after their products go off patent. And AstraZeneca ($AZN) is no exception: It's launching a direct-to-patients sales program for its breast cancer drug Arimidex. The company's "Arimidex Direct"
AstraZeneca has unveiled its "first-ever direct-to-patient programme", which will see the Anglo-Swedish drugmaker offer its breast cancer drug Arimidex to US patients for $40 a month. Under the scheme, patients with a valid prescription for Arimidex (ana
Traders concentrate on their screens at the Frankfurt stock exchange February 2, 2012. European shares were flat on Thursday morning, as gloomy outlook statements from heavyweight companies such as Unilever and AstraZeneca offset the benefit of a... View Photo »
Whether it's AstraZeneca making modern pharmaceuticals, Airbus wings from North Wales, Rolls Royce engines in Derby, or Burberry clothing in Yorkshire - those are all things that create jobs in Britain, and products we can sell to the Chinese
AstraZeneca (NYSE: AZN) today announced its first-ever direct-to-patient program offering patients with a valid prescription for ARIMIDEX or anastrozole the opportunity to have the brand ARIMIDEX delivered directly to their home by Express Scripts, a spe
MONTREAL - In the past, officials responsible for promoting Montreal’s economy have concentrated on attracting foreign investment. Now, they’ve got something else to worry about: holding on to what’s already here. Over the last year or two, there has bee
There are no results for this module. Edit this module to change the search term used to query Wikipedia
COMMERCIAL IMAGE - This infographic was provided by AstraZeneca Pharmaceuticals LP via AP Images.
View Photo »European Roundtable of Industrialists delegation AstraZeneca CEO David Brennan, Heineken CEO Jean-Francois van Boxmeer, Siemens AG CEO Peter Loscher and GDF-Suez CEO Gerard Mestrallet (L-R) leave the Elysee Palace after a meeting in Paris November 21, 2011.
View Photo »Caroline Hempstead, vice president of Global Corporate Affairs of AstraZeneca, speaks during a discussion regarding initiatives to combat non-communicable diseases at the Clinton Global Initiative in New York, September 21, 2011.
View Photo »This undated product image provided by AstraZeneca shows the pharmaceutical company's cholesterol drug Crestor. AstraZeneca PLC's big gamble, an attempt to prove its top-selling drug works better than rival cholesterol blockbuster Lipitor, appears to have backfired. A study meant to...
View Photo »AstraZeneca reminds Americans to check their cholesterol levels during National Cholesterol Education Month.
View Photo »MACCLESFIELD, ENGLAND - FEBRUARY 02: A general view of buildings and signage at the Macclesfield site of pharmaceutical company AstraZenica on February 2, 2012 in Macclesfield, England. The global pharmaceutical company has today announced that it is to shed up to 7300 jobs as part of...
View Photo »Traders concentrate on their screens at the Frankfurt stock exchange February 2, 2012. European shares were flat on Thursday morning, as gloomy outlook statements from heavyweight companies such as Unilever and AstraZeneca offset the benefit of a potential merger of Xstrata and...
View Photo »Traders work at their desks in front of the DAX board at the Frankfurt stock exchange February 2, 2012. European shares were flat on Thursday morning, as gloomy outlook statements from heavyweight companies such as Unilever and AstraZeneca offset the benefit of a potential merger of...
View Photo »Solar Panels at AstraZeneca's Wilmington, DE Campus.
View Photo »RUSSIA - JUNE 16: David Brennan, Chief Executive Officer of AstraZeneca, attends the St. Petersburg International Economic Forum (SPIEF) on June 16, 2011 in St. Petersburg, Russia. Global business leaders have gathered in Russia for the three-day conference starting today.
View Photo »European Roundtable of Industrialists delegation: Heineken CEO Jean-Francois van Boxmeer (L), Siemens AG CEO Peter Loscher (2nd L), AstraZeneca CEO David Brennan (3rd L) and GDF-Suez CEO Gerard Mestrallet (R) arrive for a meeting at the Elysee palace in Paris November 21, 2011.
View Photo »COMMERCIAL IMAGE - In this photograph released by AP Images for Young Health Programme on Monday, Nov, 28, 2011, a photo taken by eighteen-year-old Baltimore resident Brittany McAdams describes her health environment: a youth walking in an alley littered with garbage. This image is one...
View Photo »COMMERCIAL IMAGE - This infographic was provided by AstraZeneca Pharmaceuticals LP via AP Images.
View Photo »Matt's experience at AstraZeneca UK and his insights about the EU market will help Myoderm to do an even better job of providing the optimal sourcing solution for each of our clients. I know he'll be a great addition to our team.
Whether it's AstraZeneca making modern pharmaceuticals, Airbus wings from North Wales, Rolls Royce engines in Derby, or Burberry clothing in Yorkshire - those are all things that create jobs in Britain, and products we can sell to the Chinese
AstraZeneca did not need to appreciate which component was responsible for stabilization
Marion's leadership, vision and extensive experience will help AstraZeneca and the patients we serve well at a critical time for our business in the United States.
Leveraging Cognizant’s IT and business process expertise allows AstraZeneca to focus more time, energy and investment on clinical activities that will make a difference in developing innovative medicines more quickly for patients
We look at core areas of interest to AstraZeneca, in terms of therapeutic areas, but we also look more broadly into what we call 'white spaces' that are areas that AstraZeneca may look at strategically in future, or may enter into for pharmaceutical development such as diagnostics, or to help their IT
Estamos encantados de haber sido seleccionados por AstraZeneca para ofrecer bioestadísticas y servicios de reporte médico
Aprovechando la experiencia de Cognizant en TI y procesos de negocio le permitirá a AstraZeneca focalizar más tiempo, energía e inversión en aquellas actividades clínicas que marcarán una diferencia en el desarrollo de medicamentos innovadores más rápidamente para los pacientes
We are strongly committed to leveraging the domain and process knowledge of our experienced biostatisticians and medical writers to support AstraZeneca through improved decision-making, process standardization, consistency of delivery, and cost savings, which they can reinvest to support the fast, innov...
We are pleased to have been selected by AstraZeneca to provide biostatistics and medical reporting services
With the additional funding from AstraZeneca, we look forward to expanding our investment activities globally and across therapy areas. We believe that in the current financial environment, there is a growing role for corporate venture capital funds such as MedImmune Ventures
The High Court denied AstraZeneca’s obligation to warn against fatal ILD in the Warning section of the package insert ... The judgment claims that establishment of clear causal relationship between drug administration and deaths was required to impose such obligation. The High Court made a fatal mistake...
The biggest funders, including such firms as AstraZeneca, Blue Cross Blue Shield and Novo Nordisk, were also eligible to receive discounts on ‘products and workshops’ from other Gingrich groups.
All of the accusations against the AstraZeneca and Aptium current and former employees (as with those directed at the corporate entities) are patently false. These employees have never tortured or killed any animals. Neither do they exercise any control with respect to HLS animal testing
